[Federal Register Volume 60, Number 23 (Friday, February 3, 1995)] [Notices] [Pages 6719-6720] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 95-2624] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Advisory Council; Notice of Meeting In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Public Law 92-463), announcement is made of the following National Advisory body scheduled to meet during the month of March 1995. Name: Advisory Commission on Childhood Vaccines (ACCV). Date and Time: March 1, 1995; 9:00 am-5:00 pm; March 2, 1995; 9:00 am-12:00 noon. [[Page 6720]] Place: Parklawn Building, Conference Rooms G & H, 5600 Fishers Lane, Rockville, Maryland 20857. The meeting is open to the public. Purpose: The Commission: (1) Advises the Secretary on the implementation of the Program, (2) on its own initiative or as the result of the filing of a petition, recommends changes in the Vaccine Injury Table, (3) advises the Secretary in implementing the Secretary's responsibilities under section 2127 regarding the need for childhood vaccination products that result in fewer or no significant adverse reactions, (4) surveys Federal, State, and local programs and activities relating to the gathering of information on injuries associated with the administration of childhood vaccines, including the adverse reaction reporting requirements of section 2125(b), and advises the Secretary on means to obtain, compile, publish, and use credible data related to the frequency and severity of adverse reactions associated with childhood vaccines, and (5) recommends to the Director of the National Vaccine Program research related to vaccine injuries which should be conducted to carry out the National Vaccine Injury Compensation Program. Agenda: Agenda items will include, but not be limited to: a vaccine safety update from the Centers for Disease Control and Prevention and the Food and Drug Administration; a report on Children with Special Needs; a report on the National Vaccine Program; and routine Program reports. Public comment will be permitted before noon and at the end of the full Commission meeting on March 1; and before the Commission adjourns on the second day on March 2. Oral presentations will be limited to 5 minutes per public speaker. Persons interested in providing an oral presentation should submit a written request, along with a copy of their presentation to Mr. Jerry Anderson, Principal Staff Liaison, Division of Vaccine Injury Compensation, Bureau of Health Professions, Health Resources and Services Administration, Room 8A-35, 5600 Fishers Lane, Rockville, MD 20852; Telephone (301) 443-1533. Requests should contain the name, address, telephone number, and any business or professional affiliation of the person desiring to make an oral presentation. Groups having similar interests are requested to combine their comments and present them through a single representative. The allocation of time may be adjusted to accommodate the level of expressed interest. The Division of Vaccine Injury Compensation will notify each presenter by mail or telephone of their assigned presentation time. Persons who do not file an advance request for presentation, but desire to make an oral statement, may sign up in Conference Rooms G & H before 10:00 a.m. on March 1 and 2. These persons will be allocated time as time permits. Anyone requiring information regarding the Commission should contact Mr. Anderson, Division of Vaccine Injury Compensation, Bureau of Health Professions, Room 8A-35, 5600 Fishers Lane, Rockville, Maryland 20852; Telephone (301) 443-1533. Agenda Items are subject to change as priorities dictate. Dated: January 30, 1995. Jackie E. Baum, Advisory Committee Management Officer, HRSA. [FR Doc. 95-2624 Filed 2-2-95; 8:45 am] BILLING CODE 4160-15-P